Free Trial
CVE:RVV

Revive Therapeutics (RVV) Stock Price, News & Analysis

Revive Therapeutics logo
C$0.08 +0.01 (+14.29%)
As of 07/22/2019

About Revive Therapeutics Stock (CVE:RVV)

Key Stats

Today's Range
C$0.08
C$0.09
50-Day Range
C$0.08
C$0.08
52-Week Range
C$0.07
C$0.25
Volume
212,852 shs
Average Volume
93,085 shs
Market Capitalization
C$5.79 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Revive Therapeutics Ltd. develops and commercializes cannabinoid-based products in Canada. The company develops REV-002, a bucillamine that has completed Phase II-A clinical studies for the treatment of acute gout flares. Its product pipeline also includes REV-004, a bucillamine for the treatment of cystinurial. The company has a research and development supply and collaboration agreement with WeedMD Inc. Revive Therapeutics Ltd. was incorporated in 2012 and is headquartered in Vaughan, Canada.

Receive RVV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Revive Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

RVV Stock News Headlines

Revive Therapeutics Ltd. (RVV.NE)
Trump to redistribute trillions of dollars
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
Revive Therapeutics Ltd. (RVVTF)
See More Headlines

RVV Stock Analysis - Frequently Asked Questions

Revive Therapeutics' stock was trading at C$0.08 at the beginning of the year. Since then, RVV shares have increased by 0.0% and is now trading at C$0.08.
View the best growth stocks for 2025 here
.

Shares of RVV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Revive Therapeutics investors own include Aurora Cannabis (ACB), IntelGenx Technologies (IGXT), Vaxart (VXRT), Plug Power (PLUG), Sorrento Therapeutics (SRNE), Green Organic Dutchman (TGOD) and Zoom Video Communications (ZM).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
CVE:RVV
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
C$0.03 per share
Price / Cash Flow
3.18
Book Value
C$0.02 per share
Price / Book
4.21

Miscellaneous

Free Float
N/A
Market Cap
C$5.79 million
Optionable
Not Optionable
Beta
N/A
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (CVE:RVV) was last updated on 5/4/2025 by MarketBeat.com Staff
From Our Partners